---
figid: PMC9444135__fimmu-13-947885-g001
figtitle: 'Purinergic receptors are a key bottleneck in tumor metabolic reprogramming:
  The prime suspect in cancer therapeutic resistance'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Human gammaherpesvirus 4
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Drosophila melanogaster
pmcid: PMC9444135
filename: fimmu-13-947885-g001.jpg
figlink: /pmc/articles/PMC9444135/figure/f1/
number: F1
caption: The effect of purinergic receptors on tumorigenesis and tumor cell metabolism.
  After binding to ATP, the purinergic receptor, P2X7R, removes K+ from the cell as
  Ca2+ and Na+ enter the cell. Also, extracellular ATP, due to the enzymatic function
  of CD39 and CD73, is converted to AMP and ADO. By binding to P1 receptors, ADO has
  tumor-promoting effects by inhibiting the immune response. Stimulation of the P1
  receptor also causes activation of Akt and HIF-1a. An increase in intracellular
  Ca2+ activates PKC and PI3K, and PI3K by converting PIP2 to PIP3 activates Akt.
  As the main regulator, Akt activates HIF-1a, mTOR/VEGF, and NF-kb pathways and inactivates
  GSK-3, eventually leading to apoptosis inhibition, EMT, invasion, survival, and
  proliferation. Akt stimulates the glycolysis pathway. Glycolysis and OXPHOS or cell
  damage can produce ATP, leaving the cell through the PANX receptor. After binding
  to ATP, another purinergic receptor, P2YR, can increase ICAM-1, VCAM-1, and MMP,
  leading to adhesion and invasion of tumor cells. ADO, adenosine; AMP, adenosine
  monophosphate; ATP, adenosine triphosphate; CD39, cluster of differentiation 39;
  CD73, cluster of differentiation 73; DC, dendritic cell; EMT, epithelial-mesenchymal
  transition; GSK-3, glycogen synthase kinase-3; HIF-1a, hypoxia-inducible factor
  1-alpha; ICAM-1, intercellular Adhesion Molecule 1; MMP, matrix metallopeptidase;
  mTOR, mammalian target of rapamycin; NF-kb, nuclear factor kappa B; NK cell, natural
  killer cell; OXPHOS, oxidative phosphorylation; PANX, pannexin; PI3K, phosphoinositide
  3-kinases; PIP2, phosphatidylinositol-4, 5-bisphosphate; PIP3, phosphatidylinositol-3,
  4, 5-triphosphate; PKC, protein kinase C; TAM, tumor-associated macrophage; Th2,
  T helper type 2; Treg, regulatory T cell; VCAM-1, vascular cell adhesion molecule
  1; VEGF, vascular endothelial growth factor.
papertitle: 'Purinergic receptors are a key bottleneck in tumor metabolic reprogramming:
  The prime suspect in cancer therapeutic resistance.'
reftext: Hamid Aria, et al. Front Immunol. 2022;13:947885.
year: '2022'
doi: 10.3389/fimmu.2022.947885
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: therapy resistance | tumor microenvironment | metabolic reprogramming |
  purinergic receptor | cancer metabolism | immunometabolism
automl_pathway: 0.9437135
figid_alias: PMC9444135__F1
figtype: Figure
redirect_from: /figures/PMC9444135__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9444135__fimmu-13-947885-g001.html
  '@type': Dataset
  description: The effect of purinergic receptors on tumorigenesis and tumor cell
    metabolism. After binding to ATP, the purinergic receptor, P2X7R, removes K+ from
    the cell as Ca2+ and Na+ enter the cell. Also, extracellular ATP, due to the enzymatic
    function of CD39 and CD73, is converted to AMP and ADO. By binding to P1 receptors,
    ADO has tumor-promoting effects by inhibiting the immune response. Stimulation
    of the P1 receptor also causes activation of Akt and HIF-1a. An increase in intracellular
    Ca2+ activates PKC and PI3K, and PI3K by converting PIP2 to PIP3 activates Akt.
    As the main regulator, Akt activates HIF-1a, mTOR/VEGF, and NF-kb pathways and
    inactivates GSK-3, eventually leading to apoptosis inhibition, EMT, invasion,
    survival, and proliferation. Akt stimulates the glycolysis pathway. Glycolysis
    and OXPHOS or cell damage can produce ATP, leaving the cell through the PANX receptor.
    After binding to ATP, another purinergic receptor, P2YR, can increase ICAM-1,
    VCAM-1, and MMP, leading to adhesion and invasion of tumor cells. ADO, adenosine;
    AMP, adenosine monophosphate; ATP, adenosine triphosphate; CD39, cluster of differentiation
    39; CD73, cluster of differentiation 73; DC, dendritic cell; EMT, epithelial-mesenchymal
    transition; GSK-3, glycogen synthase kinase-3; HIF-1a, hypoxia-inducible factor
    1-alpha; ICAM-1, intercellular Adhesion Molecule 1; MMP, matrix metallopeptidase;
    mTOR, mammalian target of rapamycin; NF-kb, nuclear factor kappa B; NK cell, natural
    killer cell; OXPHOS, oxidative phosphorylation; PANX, pannexin; PI3K, phosphoinositide
    3-kinases; PIP2, phosphatidylinositol-4, 5-bisphosphate; PIP3, phosphatidylinositol-3,
    4, 5-triphosphate; PKC, protein kinase C; TAM, tumor-associated macrophage; Th2,
    T helper type 2; Treg, regulatory T cell; VCAM-1, vascular cell adhesion molecule
    1; VEGF, vascular endothelial growth factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATP8A2
  - ICAM1
  - VCAM1
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - CAT
  - CRAT
  - GLYAT
  - BRD2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - WDTC1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - ENTPD1
  - APRT
  - MFAP1
  - GSK3A
  - GSK3B
  - TAM
  - STIM1
  - NFKB1
  - NT5E
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - HIF1A
  - SETD2
  - ARNT
  - ITK
  - SLC22A3
  - Icam1
  - Vcam1
  - Cat
  - Nat1
  - Pik3cg
  - Svs4
  - Prkcg
  - Tmprss5
  - Nfkb1
  - Nt5e
  - Akt1
  - Mtor
  - Vegfa
  - Slc22a3
  - cac
  - Mip
  - Trpv6
  - Glyat
  - P2rx7
  - Brd2
  - Scn11a
  - Pik3r1
  - Wdtc1
  - Mdga2
  - Entpd1
  - Gsk3b
  - Itk
  - ATPsynbeta
  - Atpalpha
  - Panx
  - Mmp1
  - Ca-alpha1T
  - ChAT
  - sv
  - na
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - adp
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Amph
  - sgg
  - dc
  - PolG1
  - pyd
  - Dif
  - dl
  - Rel
  - Akt
  - Tor
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - tgo
  - sima
---
